Literature DB >> 23142825

Perugia ileal neobladder: functional results and complications.

Massimo Porena1, Luigi Mearini, Alessandro Zucchi, Michele Del Zingaro, Ettore Mearini, Antonella Giannantoni.   

Abstract

PURPOSE: To evaluate the long-term functional results and complications of an orthotopic ileal neobladder, defined as perugia ileal neobladder (PIN), in a group of patients with bladder cancer who underwent radical cystectomy (RC).
METHODS: Between 1993 and 2009, 237 consecutive patients who underwent RC for non-metastatic bladder cancer and orthotopic ileal neobladder reconstruction were enrolled. The neobladder was created using a modified Camey-II technique and consisted of a detubularized ileal loop of 45 cm using a vertical "Y" shape. Complications (<90 days) were reviewed and staged according to Clavien-Dindo classification and evaluated at long-term follow-up. Standard monitoring for cancer recurrence (computerized tomography, bone scan), cystourethrography, urodynamics and frequency/volume charts were performed during follow-up.
RESULTS: The median follow-up was 64 months, and the 5-year overall survival rate was 64 %. Early complications were mostly grade I and II; grade III and IV complications were observed in 27 patients. Perioperative mortality rate was 1.6 %. The most frequent late complications were neobladder-ureteral reflux, urolithiasis and urethral anastomotic stricture. Daytime and nighttime urinary continence were 93.5 and 83.9 %, respectively. All patients were able to completely empty neobladders. Twenty patients were followed up for at least 10 years and presented satisfactory functional results.
CONCLUSIONS: Surgical morbidity of RC and orthotopic neobladder was significant; however, the rate of grade III-IV complications was low. The long-term functional results of the PIN were interesting, confirming that appropriate patients' selection, adequate surgical technique, accurate patients' counseling and follow-up are essential.

Entities:  

Mesh:

Year:  2012        PMID: 23142825     DOI: 10.1007/s00345-012-0985-z

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  26 in total

1.  Lessons learned from 1,000 neobladders: the 90-day complication rate.

Authors:  Richard E Hautmann; Robert C de Petriconi; Bjoern G Volkmer
Journal:  J Urol       Date:  2010-09       Impact factor: 7.450

2.  Voiding dysfunction in ileal neobladder.

Authors:  N Mikuma; T Hirose; A Yokoo; T Tsukamoto
Journal:  J Urol       Date:  1997-10       Impact factor: 7.450

3.  Long-term voiding pattern of patients with ileal orthotopic bladder substitutes.

Authors:  Stephan Madersbacher; Karin Möhrle; Fiona Burkhard; Urs E Studer
Journal:  J Urol       Date:  2002-05       Impact factor: 7.450

Review 4.  A critical analysis of orthotopic bladder substitutes in adult patients with bladder cancer: is there a perfect solution?

Authors:  Wassim Kassouf; Richard E Hautmann; Bernard H Bochner; Seth P Lerner; Renzo Colombo; Alexandre Zlotta; Urs E Studer
Journal:  Eur Urol       Date:  2010-05-22       Impact factor: 20.096

5.  Functional lower urinary tract voiding outcomes after cystectomy and orthotopic neobladder.

Authors:  D J Parekh; W B Gilbert; J A Smith
Journal:  J Urol       Date:  2000-01       Impact factor: 7.450

6.  Functional results following vescica ileale Padovana (VIP) neobladder: midterm follow-up analysis with validated questionnaires.

Authors:  Giacomo Novara; Vincenzo Ficarra; Anila Minja; Vincenzo De Marco; Walter Artibani
Journal:  Eur Urol       Date:  2010-01-16       Impact factor: 20.096

7.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

Authors:  N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes
Journal:  J Natl Cancer Inst       Date:  1993-03-03       Impact factor: 13.506

8.  Are sexual activity and satisfaction affected by pelvic floor disorders? Analysis of a community-based survey.

Authors:  Emily S Lukacz; Emily L Whitcomb; Jean M Lawrence; Charles W Nager; Richard Contreras; Karl M Luber
Journal:  Am J Obstet Gynecol       Date:  2007-07       Impact factor: 8.661

9.  Long-term results of orthotopic neobladder reconstruction after radical cystectomy.

Authors:  J N Kulkarni; C S Pramesh; S Rathi; G H Pantvaidya
Journal:  BJU Int       Date:  2003-04       Impact factor: 5.588

10.  The ileal neobladder: complications and functional results in 363 patients after 11 years of followup.

Authors:  R E Hautmann; R de Petriconi; H W Gottfried; K Kleinschmidt; R Mattes; T Paiss
Journal:  J Urol       Date:  1999-02       Impact factor: 7.450

View more
  4 in total

1.  Robot-Assisted Laparoscopic Radical Cystectomy and Modified Y-Shaped Ileal Orthotopic Neobladder Reconstruction.

Authors:  Weipu Mao; Shuqiu Chen; Lijie Zhang; Tao Li; Si Sun; Bin Xu; Weidong Zhu; Guangyuan Zhang; Lei Zhang; Jianping Wu; Ming Chen
Journal:  Front Surg       Date:  2022-06-01

2.  Development of bioabsorbable zinc-magnesium alloy wire and validation of its application to urinary tract surgeries.

Authors:  Yasuyoshi Okamura; Nobuyuki Hinata; Taichi Hoshiba; Tatsuya Nakatsuji; Naoko Ikeo; Junya Furukawa; Kenichi Harada; Yuzo Nakano; Takumi Fukumoto; Toshiji Mukai; Masato Fujisawa
Journal:  World J Urol       Date:  2020-02-28       Impact factor: 4.226

3.  Long-term outcome of spiral ileal neobladder with orthotopic ureteral reimplantation.

Authors:  Huan Zhong; Yuefan Shen; Zixiang Yao; Xiaonong Chen; Jianguo Gao; Anping Xiang; Weigao Wang
Journal:  Int Urol Nephrol       Date:  2019-09-27       Impact factor: 2.370

4.  Comparison Between Ambulatory and Conventional Urodynamics of the Modified Orthotopic Hautmann Neobladder.

Authors:  Malioris Apostolos; Dimitriadis Georgios; Kampantais Spyridon; Gkotsos Georgios; Vakalopoulos Ioannis; Ioannidis Stavros; Hatzimoutatidis Konstantinos; Hatzichristou Dimitrios
Journal:  Int Neurourol J       Date:  2015-12-28       Impact factor: 2.835

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.